Aeglea BioTherapeutics, Inc. AGLE
12.01 +12.01
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 2.33M | 18.74M | 0 | 0 | 3.89M | |
| 2.33M | 18.74M | 0 | 0 | 3.89M | |
| -84.78M | -65.65M | -81.48M | -80.33M | -45.46M | |
| -83.81M | -65.80M | -80.89M | -78.25M | -44.35M | |
| -0.99 | -1.00 | -1.52 | -2.45 | -2.13 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 36.42M | 16.98M | 91.94M | 20.75M | 22.46M | |
| 71.14M | 109.93M | 161.62M | 83.18M | 77.74M | |
| 20.84M | 25.98M | 21.79M | 23.10M | 10.31M | |
| 4.63M | 5.04M | 5.45M | 5.06M | 0 | |
| 50.30M | 83.94M | 139.83M | 60.08M | 67.43M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -80.14M | -53.72M | -75.78M | -65.69M | -32.19M | |
| 57.01M | -22.62M | -7.60M | -1.74M | -15.23M | |
| 42.68M | 1.39M | 154.51M | 65.72M | 57.07M | |
| -38.00K | -573.00K | -4.28M | -1.49M | -422.00K | |
| 19.44M | -74.96M | 71.18M | -1.71M | 9.64M |